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ABSTRACT  Choline and neostigmine markedly antagonize  the effect of acetyl- 
choline (ACh) on the action potential of the venom-treated squid axon, although 
they themselves  have no effect on conduction. Physostigmine also antagonizes 
the blocking action of ACh at a concentration well below that which has any 
effect on conduction. In contrast, d-tubocurarine (curare) increases the effect of 
ACh on the action potential. Choline, neostigmine, and physostigmine mark- 
edly decrease the penetration of C14-1abeled ACh into the axoplasm of the squid 
axon. Curare, in contrast, increases the penetration of ACh, whereas dimethyl- 
curare gives variable results. The results provide an explanation why physostig- 
mine and neostigrnine  do not influence the action of ACh on axonal conduction 
in a way similar to that observed at the junction. The additive effect of curare 
and ACh on the action potential may be due either to the greater rate of pene- 
tration of ACh or to an additive effect of the two compounds on the receptor, or 
to a combination of both factors. 
INTRODUCTION 
The electrical activity of the squid giant axon is normally unaffected by the 
external application of even very high concentrations of acetylcholine (ACh), 
neosdgmine,  d-tubocurarine  (curare),  and  other  lipid-insoluble quaternary 
nitrogen compounds. Nachmansohn attributed this failure to the existence of 
permeability barriers for these lipid-insoluble compounds. He and his asso- 
ciates have shown that these compounds do not penetrate into the axoplasm 
of the  squid  axon  in  contrast  to  the  lipid-soluble  compounds which  affect 
electrical activity (1-3).  If ACh has an essential role in axonal conduction as 
postulated  by  Nachmansohn  (4),  a  reduction  of the  barriers  surrounding 
the squid axon may allow the demonstration of an effect of ACh. An action 
of ACh  and curare  on  the electrical activity of the  squid axon has indeed 
been demonstrated by pretreatment of the axon with certain snake venoms 
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(5-8).  It  has  also  been  shown  with  the  use  of radioactive  tracers  that  the 
ability of a venom to render the squid axon sensitive to ACh or curare is cor- 
related  with  its  ability  to  alter  the  penetration  of these  compounds  (3).  A 
surprising  result  in  these  studies  was  the  finding  that  physostigmine  at  low 
concentrations  when  applied  in  combination  with ACh  did  not  enhance  its 
action,  as  would  have  been  expected  with  a  potent  esterase  inhibitor,  but 
markedly  antagonized  its  action  (7).  Similar  unexpected  observations  had 
previously been made on the vagus and lobster nerves  (9,  10). The effects of 
curare  and ACh were additive. 
These  results  were  quite  unexpected  for  the  following reasons.  It  is  well 
established  that  physostigmine  applied  at  low  concentrations  to  synaptic 
and  neuromuscular  junctions  potentiates  the  action  of ACh  while  at  high 
concentration  it blocks the effect. Physostigmine is a  potent and  competitive 
inhibitor  of ACh-esterase  and  therefore  these  effects  were  to  be  expected, 
since partial  block of the enzyme should increase the persistence of ACh and 
therefore its effect, while high  concentrations  should  abolish all enzyme and 
consequently  all  electrical  activity.  Recently  it  was  demonstrated  on  the 
monocellular  electroplax  that  in  addition  physostigmine  at  certain  concen- 
trations  may also compete with ACh  for  the receptor  and  act  as a  receptor 
inhibitor,  the affinity to the receptor,  however,  being much lower than  that 
to the esterase  (10 a). 
On  the  axon  physostigmine  blocks conduction  in  high  concentrations,  as 
has been shown in extensive studies by Nachmansohn  and his associates  (4). 
The  combined  effect of ACh  and  physostigmine  has  not  been  studied  since 
until  recently  no  preparations  were  known  to  be  sensitive  to  ACh.  Nach- 
mansohn suggested that there may be a competition between these compounds 
for the pathways of penetration  in the structures surrounding  the conducting 
membrane;  i.e.,  external  to the receptor areas of the  membrane.  This paper 
presents the results of further  investigation into the effects of ACh applied in 
combination with related  compounds on the electrical  activity of, and pene- 
tration  into  the  axoplasm  of,  venom-treated  squid  axons  as  compared  with 
the effects of ACh alone. 
MATERIALS  AND  METHODS 
The preparation of the giant axon and the method of recording electrical activity with 
external  electrodes have  been  described  previously  (3,  6).  Cottonmouth  moccasin 
venom (Agkistrodonp. piscivorus),  25/~g/ml, was applied to the axon for 30 min., during 
which time it had little or no effect on electrical activity; when I00 #g/ml venom was 
used it was applied until block of electrical activity occurred (20 to 40 rain.).  Follow- 
ing rinsing in sea water for  10 min.,  the axon was exposed for 60 min.  to ACh or to 
ACh plus another compound. In previous studies (3) it appeared that there was more 
variability in the penetration  of compounds from squid to squid than from axon to 
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results  are presented in a  paired fashion, one axon from each squid being exposed to 
ACh alone, whereas the other was exposed to ACh combined with another compound. 
The  results  were  then  statistically  analyzed  by  the  method  of paired  comparisons 
(mean of differences). The method of extruding axoplasm and measuring its radioac- 
tivity has been described (3). All counts were corrected for the over-all efficiency of the 
counting system  (about  80  per  cent)  to  give  the  actual  disintegrations  per  minute. 
Each  axon  was  exposed  to  a  radioactivity  of  C14-ACh  which  varied  from  0.62 
to  1.23  X  106 disintegrations/minute/ml  and was accurately known for each experi- 
ment. The average weight of axoplasm extruded was 4.3 mg with a range from 1 to 10 
mg. The disintegrations/minute/sample  that would have been expected if no barrier 
TABLE  I 
EFFECT  OF ACETYLCHOLINE (ACh)  ALONE AND  IN 
PRESENCE  OF  CHOLINE,  NEOSTIGMINE,  OR  PHYSOSTIGMINE 
ON ELECTRICAL ACTIVITY OF THE  SQUID AXON 
All  axons  were  pretreated  with  25/zg/rnl  cottonmouth 
moccasin venom for 30 rain.  ACh concentration, 4.5  X 
10  -3 M. The results are given as means -4- standard devia- 
tions of the mean. 
No. of  Action potential 
Exposure  experiments  (Decrease in 60 min.) 
ACh 
ACh -b choline 2.7  X  10  -8 M 
ACh q- choline 5.4 X  10  -8 
ACh q- choline 2.7  X  10  -2 M 
ACh -k neostigmine 1.7 X  10  -2 M 
ACh -b physostigminc 5 X  10  -4 m 
ACh +  physostigmine 5 X  10  -3 M 
psr c~nt 
27  90  -4- 5 
3  73  4- 27 
6  42  4-  11 
9  184-7 
9  32  4-9 
4  28  -4-9 
2  41  4-  13 
existed and equilibrium had been achieved are recorded in the tables and were calcu- 
lated  as  previously  reported  (3),  allowing  for  differences  in  radioactivity  and 
in amounts of axoplasm extruded. 
Acetylcholine  (N-methyl-C10  chloride was obtained from New  England  Nuclear 
Corporation.  Crystalline non-radioactive dimethyl-d-tubocurarine  diiodide  was  pur- 
chased from Eli  Lilly and  Company,  while  d-tubocurarine  chloride  was  purchased 
from K  and  K  Laboratories,  Inc., New York.  Lyophilized cottonmouth venom (lot 
6/29/61)  was purchased from Ross Allen Reptile Institute, Silver Springs, Florida. 
RESULTS 
It  was  of interest  to  test  whether  a  compound  with  no  effect  on  electrical 
activity could modify the action of ACh.  Earlier  studies  had  shown that even 
following  cottonmouth  venom  treatment  7.2  X  10  -2 ~t  choline  had  little  or 
no effect on the  action potential  of the  squid  axon  (6).  In additional  studies 
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TABLE  II 
PENETRATION  OF  ACETYLCHOLINE  (ACh) 
ALONE  AND  IN  PRESENCE  OF  CHOLINE  INTO 
AXOPLASM OF  SQUID  AXON 
In series 1 and 2 the axons were pretreated for 30 rain. with 
25/~g/ml venom,  in  series 3 with 100/~g/ml. The concen- 
tration  of  CX4-ACh  was 4.5  M  10  -a M in  all  experiments; 
non-radioactive  choline  2.7  X  10  -3 M in  series  1  and  2.7 
X  10  -~ M in series 2  and 3. The expected  values  are those 
which  would  be  found  in  the  axoplasm  if  there  was  no 
barrier. The time  of exposure  was  in  all  experiments  60 
rain. 
Series 
Di~integratiom/min./ 
sample 
Exposure  Expected  Found  Penetration 
per Cent 
ACh  5659  227  4.0 
ACh +  choline  3010  20  0.7 
ACh  2288  80  3.5 
ACh +  choline  2231  70  3.1 
ACh  1952  120  6.2 
ACh +  choline  1911  98  5.1 
ACh  2445  132  5.4 
ACh +  choline  2141  8  0.4 
ACh  4282  53  1.2 
ACh +  choline  4241  24  0.6 
ACh  3101  194  6.3 
ACh +  choline  3298  42  1.3 
ACh  1077  236  21.9 
ACh +  choline  1514  268  24.3 
ACh  2732  587  21.5 
ACh +  choline  1600  656  41.0 
ACh  3101  2154  69.5 
ACh +  choline  5261  3338  63.5 
the squid  axon,  5  ×  10 -2  M neostigmine  caused  less  than  a  10  per  cent  de- 
crease  in  spike  height  in  60  min.  (seven  experiments).  However,  Table  I 
shows  that both choline  (5.4  ×  10  .3  M and  2.7  ×  10  .5 M)  and  neostigmine 
markedly  antagonized  the effect of ACh on  the action potential  (P  <  0.01). 
The  effects on  the  amplitude  of the action potential  observed  in  the experi- 
ments using  CI*-ACh  (Tables  II  to V)  are  also  included  in Table  I.  Earlier 
studies  (7)  had  shown  that  physostigmine  also  markedly  antagonized  the 
action  of ACh,  and,  using  different  concentrations  of these  two  agents,  we 
confirmed  this  observation  (Table  I).  Curare,  on  the  other  hand,  does  not 
antagonize  the  block  of  conduction  by  ACh  in  venom-treated  axons,  but 
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Having  obtained  information  concerning  the  effects  of  the  compounds 
applied either alone or in combination with ACh on axonal conduction, we 
undertook studies with radioactive compounds to see how well these effects 
could be correlated with the penetration of ACh. 
Following pretreatment of axons for 30 min. with 25 ~g/ml venom, which 
had  no effect on  the height of the  action potential,  2.7  X  10  -* M choline 
markedly decreased (P <  0.02) the penetration of ACh (Table II). Even 2.7 
X  10  -3  M choline showed some evidence of antagonism  (P  <  0.10).  With 
100 #g/ml venom, which by itself blocks electrical activity and greatly reduces 
the permeability barriers, no antagonism to ACh by choline is observed. 
TABLE  III 
PENETRATION  OF  ACETYLCHOLINE  (ACh) 
ALONE  AND  IN  PRESENCE  OF  NEOSTIGMINE 
INTO  AXOPLASM OF  SQUID  AXON 
Axons were pretreated for 30 rain. with 25/zg/ml venom. 
The concentration of CX4-ACh was 4.5 X  10  -3 M in all the 
experiments; non-radioactive neostigmine, 1.7 X  10  -2 ~a. 
Disint  egrations/min./sample 
Exposure  Expected  Found  Penetration 
per ~nt 
ACh  2371  106  4.5 
ACh n  t- neostigmine  2346  34  1.5 
ACh  2716  44  1.6 
ACh +  neostigmine  2445  18  0.7 
ACh  2822  72  2.6 
ACh +  neostigmine  4045  49  1.2 
Neostigmine also significantly decreased the penetration of ACh as seen in 
Table III  (P <  0.01). 
The penetration of ACh as influenced by physostigmine is shown in Table 
IV.  In three of the four experiments, 5  X  10  -~ u  physostigmine markedly 
decreased  the  penetration  of" ACh.  In  all  four  experiments physostigmine 
markedly decreased the effect of ACh on the action potential  (Table I).  In 
the  two  experiments performed  5  X  10  -3  M physostigmine decreased  the 
penetration of ACh (Table IV) and the effect of ACh on the action potential 
(Table I). 
Table V  shows the effect of curare on the penetration of radioactive ACh. 
Curare  did  not  decrease  but  actually  increased  the  penetration  of  ACh 
(P <  0.01). Without venom pretreatment very little radioactivity is found in 
the axoplasm (less than 1 per cent of that expected if no barrier were present). 
In  the  two  experiments in  which curare  was  added  there  seemed to  be  a 
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is questionable.  In all the experiments listed in Table V  with venom-treated 
axons,  ACh  and ACh plus  curare blocked conduction in less  than  60  min. 
In the two experiments with untreated axons, ACh and ACh plus curare had 
no effect. In order to examine the possible effects of the free phenolic hydroxyls 
in  the curare molecule, several experiments were performed with dimethyl- 
curare. The results were not consistent.  In six of the experiments, dimethyl- 
curare had an effect similar to that of curare, i.e.  it increased the penetration 
of ACh,  although less  than  curare,  whereas in  the remaining three experi- 
TABLE  IV 
PENETRATION  OF  ACETYLCHOLINE  (ACh) 
ALONE  AND  IN  PRESENCE  OF  PHYSOSTIGMINE 
INTO  AXOPLASM OF  SQUID  AXON 
Axons were pretreated for 30 rain. with 25/zg/ml venom. 
The  concentration of CI4-ACh was 4.5  X  10  -8 M in  all 
experiments; non-radioactive physostigmine, 5  X  10  -4 M 
in series 1,  and 5  X  10  -3 M in series 2. 
Series 
Disintegrations/ 
min./sample 
Exposure  Expected  Found  Penetration 
per 6ent 
ACh  2566  140  5.5 
ACh q- physostigmine  2209  19  0.9 
ACh  1760  108  6.1 
ACh -~- physostigmine  1821  51  2.8 
ACh  1837  54  2.9 
ACh q- physostigmine  2917  27  0.9 
ACh  2615  107  4.1 
ACh +  physostigmine  2098  113  5.4 
ACh  4921  112  2.3 
ACh -F physostigmine  5602  51  0.9 
ACh  7890  93  I. 2 
ACh q- physostigmine  4929  17  0.3 
ments an  antagonism was observed.  In all experiments ACh  and ACh plus 
dimethylcurare blocked conduction in less than 60 min. 
DISCUSSION 
In  most  nerve  fiber  preparations  the  conducting  membranes  seem  to  be 
surrounded  by structural  barriers  preventing  the  action  of ACh  and  other 
lipid-insoluble  quaternary  nitrogen  compounds.  In  some  preparations  the 
barriers are not completely impervious.  For example,  at  the Ranvier nodes 
of a  single frog sciatic fiber  (11),  on the desheathed rabbit vagus  (9),  or on 
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effects  of ACh,  curare,  or  other  quaternary  nitrogen  compounds  related  to 
ACh.  However, even in preparations  where  the barriers are impervious,  it is 
possible  to reduce  the  permeability barriers  and  to observe subsequently  an 
effect of ACh  (5-8,  13).  In the  present  study  the  barriers of the  squid  giant 
axon  preparation  were  reduced  by  pretreatment  with  a  concentration  of 
snake venom which had no effect on electrical activity. 
TABLE  V 
PENETRATION OF ACETYLCHOLINE (ACh) 
ALONE AND IN PRESENCE  OF d-TUBOCURARINE (CURARE) 
INTO AXOPLASM  OF  SQUID AXON 
Series 1 was pretreated with 25 ug/ml venom, series 2 was 
not pretreated. The concentration of CX4-ACh was 4.5 X 
10  -a M in all experiments; non-radioactive curare, 7.2 X 
10  -8  M. 
Disintegrations/ 
min./sample 
Series  Exposure  Expected  Found  Penetration 
per cent 
ACh  4502  343  7.6 
ACh -k- curare  3722  468  12.6 
ACh  5350  221  4.1 
ACh -k- curare  645  83  12.9 
ACh  3317  Ill  3.3 
ACh q- curare  2694  815  30.2 
ACh  2979  393  13.2 
ACh q- curare  2710  697  25.7 
ACh  4724  40  0.9 
ACh q- curare  3379  228  6.8 
ACh  6030  11  0.2 
ACh +  curare  4282  36  0.8 
ACh  1869  6  0.3 
ACh q- curare  1338  6  0.5 
In  agreement  with  earlier  observations  on  the  venom-treated  squid  axon 
(6,  7)  we find  that ACh  in appropriate concentration  usually blocks conduc- 
tion,  and  that  physostigmine  antagonizes  the  blocking  action  of ACh  even 
when  used  in  a  concentration  well  below  that  of ACh,  and  well  below  that 
having any direct  effects on conduction.  We  also find  that choline  and  neo- 
stigmine,  although  having no effect of their  own  on  conduction,  antagonize 
the  effect  of ACh  when  both  they  and  ACh  are  used  in  about  equimolar 
concentrations.  Similar  observations  on  the  rabbit  vagus  nerve  have  been 
reported  previously  (9,  14).  One  would  have  expected  that  physostigmine, 
being a  strong ACh-esterase inhibitor,  would at low concentration  potentiate 
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that physostigmine, neostigmine, and choline compete with ACh for pene- 
tration. The competition appears to be concentration-dependent  for choline. 
In contrast 5  ×  10  -4 M physostigmine decreased the penetration of ACh as 
much as 5  X  10  -3 M (Table IV) agreeing with the observation on electrical 
activity  (Table  I).  Only a  single concentration of neostigmine  was  tested. 
These antagonistic effects on penetration parallel the antagonistic effects on 
electrical activity, thus providing an explanation for the observed antagonism. 
The question may be raised whether the penetration of various compounds 
takes place through the same or through different pathways. While the ap- 
pearance of the compounds in the axoplasm does not answer this question, 
the parallelism of the block of penetration and block of action seems to us 
to exclude the assumption of different pathways and to point to a  competi- 
tion for the same pathways. The decrease of ACh penetration by physostig- 
mine, neostigmine, and the higher concentration of choline may be even more 
marked than the results indicate since penetration in over half of the experi- 
ments is  lowered  to  the  level  observed  without  venom pretreatment  (less 
than  1 per cent of that expected if no barrier were present).  As discussed 
previously  (3)  levels  of apparent  penetration below  about  1  per  cent  are 
questionable and  may not represent actual penetration.  Since neostigmine 
and physostigmine in the concentrations used have no direct effect on con- 
duction, it would be difficult to assume that they are competing with ACh for 
a  specific site in the membrane essential for electrical activity. Choline was 
found (3)  to penetrate through the membrane and into the axoplasm of the 
venom-treated preparation without having any effect on electrical activity. 
It is well known that the intrinsic activity of choline on the ACh receptor is 
very weak,  but  its  decrease of ACh penetration is  marked  (Table  II).  In 
recent still  unpublished experiments, Dr. Miro Brzin  1 found that even in the 
venom-treated axon neostigmine does not penetrate into the axoplasm. This 
further supports the assumption that the effect of neostigmine is due to reac- 
tions in the outside structure and not those on the esterase or receptor. 
The results confirm and extend the previous observations on the impor- 
tance of structural barriers surrounding the axonal conducting membranes in 
determining effects of chemical compounds on electrical activity. 
These structures affect the action of ACh and closely related compounds 
in a  complex way. As has been known for quite some time,  some of them 
penetrate through the intact barrier.  Physostigmine, for instance, which at 
the  pH  used  is  partially in  an  uncharged form,  decreases and  eventually 
blocks conduction. Other compounds (ACh, curare, choline) penetrate only 
after partial reduction of the barriers by snake venom. Finally, some com- 
pounds,  for  instance  neostigmine, do  not  penetrate  (I)  even  after  venom 
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treatment (see previous discussion). But it now has become apparent that the 
pathways in the reduced but still persisting barrier may modify the effect of 
these compounds when two of them are applied simultaneously. It is possible 
that they react with constituents in  the pathway and that this reaction de- 
pends on the structure of the compound applied. Choline, neostigmine, and 
curare are all quaternary nitrogen derivatives and may react with negatively 
charged groups. Apparently, however, they do not react in the same way in 
the squid axon preparation since curare facilitates the passage of ACh while 
choline and neostigmine decrease its passage.  In contrast,  curare markedly 
decreases the penetration of a quaternary nitrogen compound (iodocholinium) 
in skeletal muscle (15) emphasizing the variability of the interactions between 
compounds which may be observed in different preparations. The unexpected 
antagonism observed when ACh is applied in combination with either neo- 
stigrnine or physostigmine is based on an entirely different mechanism from 
that observed at the junction where these two compounds at low concentra- 
tions  inci'ease  the  action  of ACh  by  the  inhibition  of ACh-esterase,  and 
neostigmine in addition by activating the receptor. While at the junction the 
effect of these compounds is essentially due to their reactions with the macro- 
molecules of the ACh system, in particular with the receptor or the esterase, 
the effects on the axon are  influenced by reactions of the compounds with 
constituents of the structures outside of the conducting membrane, slowing 
down the penetration of ACh itself and  thereby decreasing its effects.  The 
exact  site  external  to  the receptor and  esterase  at  which these compounds 
antagonize the penetration of ACh is not known. 
For a  long time the failure of ACh to affect conduction was considered as 
crucial  evidence  against  the  role  of ACh  in  conduction,  as  postulated  by 
Nachmansohn (4).  The recently described effects of ACh on axonal conduc- 
tion  (7,  9,  19,  13)  would be  questionable as  to  their meaning without the 
evidence that  the ACh  system is present in  all  conducting fibers  (16),  has 
special properties required for  the assumption that it is responsible for  the 
ionic permeability changes, e.g.  a  very small turnover time (17), localization 
within  the conducting membranes  (18),  and is inseparably associated with 
electrical activity (4,  19, Brzin, results to be published). Armett and Ritchie 
found that externally added ACh decreased the action potential of, and de- 
polarized,  the rabbit's  vagus after removal of the sheath  (9).  However,  the 
likelihood of there being a  physiological significance in this effect was con- 
sidered somewhat remote on the basis that neostigmine and other compounds 
which have no effect on conduction antagonize the action of ACh  (14).  As 
in  the  squid  axon  the  conducting membrane  in  the  vagus  preparation  is 
surrounded by other structures, and thus it appears to us likely that an effect 
on  penetration  similar  to  that  described  here  is  the  explanation for  their 
findings.  It is  true,  however,  that without the large amount of biochemical ~i26  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  47  •  ~964 
data accumulated in favor of a role of ACh in axonal conduction, their claim 
of a  purely pharmacological action might be more justified. 
Curare  is  a  receptor  inhibitor;  ACh,  neostigmine,  and  other  quaternary 
nitrogen  derivatives  are  receptor  activators.  Although  both  types  block 
electrical activity, the activators, but not the inhibitors, depolarize the mem- 
brane.  It  is,  therefore,  not  surprising  that  at  the  neuromuscular junction 
where virtually all the pharmacological actions have been tested until recently, 
some  antagonistic  and  some  additive  effects were  described  between ACh 
and curare. An important factor is apparently the respective concentrations 
of the two compounds  (20,  21).  So far only an additive effect has been ob- 
served on the axon.  The concentrations at the active site are unknown, but 
may be several orders of magnitude smaller than those on the outside.  Ob- 
viously, it is much more difficult to control the concentration at  the active 
site  in  the  presence  of complex  barriers  than  in  their  absence.  Thus  the 
antagonistic  action  of curare may be  veiled by  the  increased rate  of ACh 
penetration.  On  the  axon  the  effects of curare are  even more complicated 
since under certain conditions curare has been observed to depolarize (6,  14), 
although  this  may be  due  to  inhibition  of cholinesterase  by  the  relatively 
high concentrations of curare used. 
Curare  is  known  to  combine  readily  with  macromolecules  containing 
negative groups such as basic brain proteins  (22,  23),  maeromolecules from 
sciatic  nerve  (24),  acidic  polysaccharides  (25),  gangliosides  (26),  casein, 
chondroitin  sulfate,  and  bovine  serum albumin  (27).  Curare  may combine 
with  negative  groups  preventing  the  binding  of the  ACh  and  increasing 
thereby  the  effective  ACh  concentration  available  for  absorption.  The 
attempt to use dimethylcurare to explore this possibility was inconclusive. 
Although  the  nature  of  the  chemical  reactions  responsible  for  altered 
permeability has not been investigated, it seems that choline competes with 
ACh  on  a  mole for mole basis  since concentrations of choline about  equal 
to that of ACh are needed to demonstrate antagonism. It is no longer possible 
to demonstrate antagonism of ACh penetration by choline when the perme- 
ability barriers to ACh are no longer the limiting factor as with the  use of 
100  ug/ml venom.  The  antagonistic action of physostigmine is  much more 
potent than that of choline since concentrations well below those of ACh are 
still antagonistic. 
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